US: Phase Forward, a provider of data management solutions for clinical trials and drug safety, announced a multi-year agreement with Quotient Clinical, which specializes in early development services for a broad range of pharmaceutical and biotech customers.

Quotient Clinical, a strategic business unit of Quotient Bioresearch, is implementing Phase Forward's InForm Global Trial Management (GTM) electronic data capture (EDC) solution to support data collection, management and analysis for its clinical trials. In addition, the company will use Phase Forward's Central Designer module to enhance eCRF design efficiency and improve workflow in the study development process for EDC trials, a press release adds.

"As an innovative provider of early drug development services, we want to ensure that our customers can take advantage of the benefits inherent in using EDC in Phase I trials, including access to high quality data within hours of collection, streamlined process efficiencies and rapid qualification of data," said Quotient's David Chalmers, vice president, Biometrics. "We selected InForm because of Phase Forward's strong position in the marketplace and the company's experience with Phase I trials."

By supporting faster accessibility and greater visibility into trial data, the EDC implementation will help Quotient to expand its full-service, in-house Biometrics offering, according to the company. In addition, Quotient plans to offer customers on-line access to trial data, making it easier for them to track progress to date or to review summary reports.